Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will IDRX-42 receive FDA Fast Track designation by mid-2025?  | Binary | 3 | 2 days ago | ||
Will IDRX-42 enter Phase 2 clinical trials by the end of 2025? | Binary | 2 | 2 days ago | ||
Will GSK report positive interim results for IDRX-42 in Phase 1 trials by Q3 2025? | Binary | 2 | 2 days ago | ||
Which milestone will GSK's IDRX-42 achieve in 2025? | Categorical | 2 | 2 days ago | ||
What will be the growth in GSK's oncology portfolio revenue in 2025? | Categorical | 2 | 2 days ago | ||
Which area will GSK prioritize in its 2025 strategy? | Categorical | 2 | 2 days ago |